¼¼°èÀÇ ¼¼Æ÷ È®Àå ½ÃÀå
Cell Expansion
»óǰÄÚµå : 1564071
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,147,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,443,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Àü ¼¼°è ¼¼Æ÷ È®Àå ½ÃÀå 2030³â±îÁö 869¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»ó

2023³â 331¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼Æ÷ È®´ë ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 14.8% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 869¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼Æ÷ È®´ë ¼Ò¸ðǰÀº ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀ̸ç, CAGR 16.0%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÌ ³¡³ª¸é 424¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼Æ÷ È®´ë Àåºñ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 12.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 91¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 13.9%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ¼¼Æ÷ È®Àå ½ÃÀåÀº 2023³â 91¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö ½ÃÀå ±Ô¸ð°¡ 131¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 13.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 13.1%¿Í 12.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 10.6%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¼¼Æ÷ È®´ë ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

¼¼Æ÷ È®´ë´Â Ä¡·á¿Í ¿¬±¸¿¡ ¾î¶² º¯È­¸¦ °¡Á®¿Ã °ÍÀΰ¡?

¼¼Æ÷ Áõ½ÄÀº »ý¹° ÀÇÇÐ ¿¬±¸¿Í ÷´Ü Ä¡·á¹ý °³¹ß¿¡¼­ ¸Å¿ì Áß¿äÇÑ °úÁ¤À¸·Î, ÇÑÁ¤µÈ Ãâ¹ß Áý´Ü¿¡¼­ ´ë·®ÀÇ ¼¼Æ÷¸¦ »ý»êÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ ±â¼úÀº Àç»ýÀÇÇÐ, Á¾¾çÇÐ, ¸é¿ªÄ¡·á µî ¿¬±¸, ½Å¾à°³¹ß, Ä¡·á¸¦ À§ÇØ ¹æ´ëÇÑ ¾çÀÇ ±â´É¼º ¼¼Æ÷°¡ ÇÊ¿äÇÑ ºÐ¾ß¿¡¼­ ±âº»ÀÌ µÇ´Â ±â¼úÀÔ´Ï´Ù. Áٱ⼼Æ÷ Ä¡·áÀÇ ¸Æ¶ô¿¡¼­ ¼¼Æ÷ Áõ½ÄÀº Á¶Á÷ Àç»ý ¹× ÅðÇ༺ ÁúȯÀ» Ä¡·áÇϱ⿡ ÃæºÐÇÑ Áٱ⼼Æ÷¸¦ »ý¼ºÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. ¾Ï ¿¬±¸¿¡¼­ T¼¼Æ÷¿Í °°Àº ¸é¿ª¼¼Æ÷¸¦ Áõ½Ä½ÃŰ´Â ´É·ÂÀº CAR-T ¼¼Æ÷ Ä¡·á¿Í °°Àº ¸é¿ªÄ¡·áÀÇ ±æÀ» ¿­¾ú½À´Ï´Ù. ¼¼Æ÷ Áõ½ÄÀº ¼¼Æ÷ÀÇ »ýÁ¸·Â°ú ±â´ÉÀ» À¯ÁöÇϸ鼭 ¼¼Æ÷ ¼ö¸¦ ´Ã¸®´Â È¿À²ÀûÀÎ ¼ö´ÜÀ» Á¦°øÇÔÀ¸·Î½á ÀÓ»ó°ú ¿¬±¸ ȯ°æ ¸ðµÎ¿¡¼­ Çõ½ÅÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. »ý¹° ¹ÝÀÀ±â ±â¼ú°ú ¹è¾ç¾×ÀÇ ¹ßÀüÀ¸·Î ¼¼Æ÷ Áõ½Ä °úÁ¤ÀÌ ´õ¿í È®Àå °¡´ÉÇϰí Á¤È®ÇØÁ® °úÇÐÀÚ¿Í ÀÓ»óÀǰ¡ ´Ù¾çÇÑ Ä¡·á ¿ëµµ¸¦ À§ÇØ °íǰÁú ¼¼Æ÷¸¦ »ý»êÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

Àç»ýÀÇ·á¿Í ¸é¿ªÄ¡·á¿¡ ¼¼Æ÷ È®ÀåÀÌ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼¼Æ÷ÀÇ È®ÀåÀº Çö´ë ÇコÄɾ¼­ °¡Àå À¯¸ÁÇÑ ºÐ¾ßÀÎ Àç»ýÀÇ·á¿Í ¸é¿ªÄ¡·áÀÇ ¹ßÀü¿¡ ÇʼöÀûÀÔ´Ï´Ù. Àç»ýÀÇÇÐÀº ´Ù¾çÇÑ ¼¼Æ÷·Î ºÐÈ­ÇÏ¿© ¼Õ»óµÈ Á¶Á÷À» º¹±¸ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» °¡Áø Áٱ⼼Æ÷¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ô¼ö ¼Õ»ó, ½ÉÀ庴, ´ç´¢º´°ú °°Àº Áõ»ó¿¡ ´ëÇÑ È¿°úÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸ÀÚµéÀº Áٱ⼼Æ÷¸¦ ´ë·®À¸·Î Áõ½Ä½ÃÄÑ¾ß ÇÕ´Ï´Ù. ÀÌ ¶§, Áٱ⼼Æ÷ÀÇ ´Ù´É¼ºÀ» À¯ÁöÇϰí ÇÊ¿äÇÑ ¼¼Æ÷·Î ºÐÈ­ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» À¯ÁöÇÏ´Â °ÍÀÌ °ü°ÇÀÔ´Ï´Ù. ¹Ý¸é, ¸é¿ªÄ¡·á´Â T¼¼Æ÷¿Í °°Àº ¸é¿ª¼¼Æ÷¸¦ Áõ½Ä½ÃŰ´Â °Í¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, CAR-T ¼¼Æ÷ Ä¡·áÀÇ ¼º°ø ¿©ºÎ´Â T¼¼Æ÷¸¦ Ä¡·á È¿°ú¸¦ ´Þ¼ºÇÒ ¼ö ÀÖÀ» ¸¸Å­ ÃæºÐÇÑ ¼ö·Î È®´ëÇÒ ¼ö ÀÖ´ÂÁö¿¡ ´Þ·Á ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ¼¼Æ÷ÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í ´ë·® »ý»êÀ» Áö¿øÇÒ ¼ö ÀÖ´Â °ß°íÇÑ ¼¼Æ÷ Áõ½Ä ½Ã½ºÅÛ¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ¼¼Æ÷ Áõ½Ä ±â¼úÀº ÀÓ»ó Àû¿ëÀÇ È®À强 ¹× ±ÔÁ¦ Áؼö ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ´õ¿í Á¤±³ÇØÁö°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¼¼Æ÷ÀÇ È®Àå¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿À°í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ¼¼Æ÷ÀÇ È®Àå °úÁ¤¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ º¸´Ù È¿À²ÀûÀ̰í È®Àå °¡´ÉÇϸç Çö´ë °úÇÐÀÇ ¿ä±¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ±â¼ú Çõ½Å Áß Çϳª´Â »ý¹° ¹ÝÀÀ±âÀÇ °³¹ßÀÔ´Ï´Ù. ¹ÙÀÌ¿À¸®¾×ÅÍ´Â ¼¼Æ÷ Áõ½ÄÀ» À§ÇÑ ÅëÁ¦µÈ ȯ°æÀ» Á¦°øÇÏ¿© »ýÁ¸·Â°ú ±â´ÉÀ» À§ÇÑ ÃÖÀûÀÇ Á¶°ÇÀ» À¯ÁöÇϸ鼭 ¼¼Æ÷¸¦ ´ë±Ô¸ð·Î È®ÀåÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ ¹ÙÀÌ¿À¸®¾×ÅÍ´Â ¿Âµµ, »ê¼Ò, ¿µ¾ç ¼öÁذú °°Àº Áß¿äÇÑ ¸Å°³º¯¼ö¸¦ ¸ð´ÏÅ͸µÇϰí Á¶Á¤ÇÏ´Â ÀÚµ¿È­ ½Ã½ºÅÛÀ» °®Ãß°í ÀÖ¾î ÀϰüµÇ°í ¹Ýº¹ °¡´ÉÇÑ °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, ¹è¾ç¾× ±â¼ú Çõ½ÅÀ» ÅëÇØ ƯÁ¤ ¼¼Æ÷ À¯Çü¿¡ ÇÊ¿äÇÑ ¿µ¾çÀ» ÃÖÀûÈ­ÇÏ¿© È®´ëµÈ ¼¼Æ÷ÀÇ Ç°Áú°ú ¼öÀ²À» ´õ¿í Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¼¼Æ÷°¡ ÇöŹ »óÅ¿¡¼­ Áõ½ÄÇÒ ¼ö Àִ ǥ¸éÀ» Á¦°øÇÏ´Â ¸¶ÀÌÅ©·Îij¸®¾î´Â ¹ÙÀÌ¿À¸®¾×ÅÍÀÇ ¿ë·®À» È®´ëÇÏ¿© °í¹Ðµµ ¼¼Æ÷¸¦ º¸´Ù È¿À²ÀûÀ¸·Î »ý»êÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù. ÀÚµ¿È­ ¹× ÀΰøÁö´É(AI)ÀÇ ¹ßÀüµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¼¼Æ÷ ¹è¾ç ȯ°æ¿¡¼­ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¿¬±¸ÀÚ¿Í ÀÓ»óÀǰ¡ Ä¡·á¿ë ¼¼Æ÷ »ý»ê¿¡ ¼Ò¿äµÇ´Â ½Ã°£°ú ºñ¿ëÀ» Àý°¨Çϰí, ÀÓ»ó ¹× »ê¾÷ ÀÀ¿ë ºÐ¾ß·Î È®À强À» ³ôÀ̰í ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

¼¼Æ÷ÀÇ È®Àå ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

¼¼Æ÷ È®´ë ½ÃÀåÀÇ ¼ºÀåÀº ¼¼Æ÷ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼úÀÇ ¹ßÀü, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, CAR-T ¼¼Æ÷ Ä¡·á ¹× Áٱ⼼Æ÷ Ä¡·á¿Í °°Àº ´õ ¸¹Àº ¼¼Æ÷ ±â¹Ý Ä¡·á¹ýÀÌ ÀÓ»ó¿¡ µµÀԵʿ¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ°í ½Å·ÚÇÒ ¼ö ÀÖ°í È®Àå °¡´ÉÇÑ ¼¼Æ÷ Áõ½Ä ¹æ¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å, ƯÈ÷ ¹ÙÀÌ¿À¸®¾×ÅÍ¿Í ÀÚµ¿È­·Î ÀÎÇØ ǰÁú°ú Ä¡·á °¡´É¼ºÀ» À¯ÁöÇϸ鼭 ´ë·®ÀÇ ¼¼Æ÷¸¦ ½±°Ô »ý»êÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¼Õ»óµÈ Á¶Á÷À» º¹±¸Çϰųª ´ëüÇϱâ À§ÇØ Áٱ⼼Æ÷¸¦ »ç¿ëÇÏ´Â Àç»ýÀÇ·á ºÐ¾ß¿¡¼­ ¼¼Æ÷ Áõ½ÄÀ» È®´ëÇÏ´Â °Íµµ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í Àִµ¥, ÀÌ·¯ÇÑ Ä¡·á¿¡ ÇÊ¿äÇÑ ´ë·®ÀÇ ¼¼Æ÷¸¦ »ý»êÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀ̰í È®Àå °¡´ÉÇÑ ½Ã½ºÅÛÀÌ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ¾Ï, ´ç´¢º´, ½ÉÇ÷°ü ÁúȯÀÇ ¹ßº´·ü Áõ°¡´Â ¸é¿ªÄ¡·á, Àç»ýÄ¡·á µî ¼¼Æ÷ È®´ë¿¡ ÀÇÁ¸ÇÏ´Â »õ·Î¿î Ä¡·á¹ý ¿¬±¸¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷ ±â¹Ý Ä¡·á¹ý ½ÂÀο¡ ´ëÇÑ ±ÔÁ¦ÀÇ ¹ßÀüÀº ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¸ÂÃãÇü ¼¼Æ÷Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡¼ÓÈ­µÇ°í Çõ½ÅÀûÀÎ ¼¼Æ÷ È®´ë ±â¼ú °³¹ß¿¡ »õ·Î¿î ±âȸ°¡ âÃâµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î ¼¼Æ÷ È®´ë ½ÃÀåÀÇ ±Þ°ÝÇÑ È®ÀåÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, »ý¸í°øÇÐ ¹× ÇコÄÉ¾î ºÐ¾ßÀÇ Áß¿äÇÑ ¼ºÀå ºÐ¾ß·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 12°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cell Expansion Market to Reach US$86.9 Billion by 2030

The global market for Cell Expansion estimated at US$33.1 Billion in the year 2023, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the analysis period. Growth in the Cell Expansion Instruments segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 13.9% CAGR

The Cell Expansion market in the U.S. is estimated at US$9.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.1% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Cell Expansion Market - Key Trends and Drivers Summarized

How Is Cell Expansion Transforming Therapeutics and Research?

Cell expansion is a pivotal process in biomedical research and the development of advanced therapies, enabling the production of large quantities of cells from a limited starting population. This technique is fundamental in fields such as regenerative medicine, oncology, and immunotherapy, where vast numbers of functional cells are required for research, drug discovery, or therapeutic use. In the context of stem cell therapy, cell expansion allows for the generation of enough stem cells to support tissue regeneration or to treat degenerative diseases. In cancer research, the ability to expand immune cells, such as T cells, has paved the way for immunotherapies like CAR-T cell treatments, which require billions of engineered immune cells to effectively target and destroy cancerous cells. By providing an efficient means of increasing cell numbers while maintaining their viability and functionality, cell expansion is driving innovation in both clinical and research environments. With advancements in bioreactor technology and culture media, the process of expanding cells has become more scalable and precise, ensuring that scientists and clinicians can produce high-quality cells for a variety of therapeutic applications.

Why Is Cell Expansion Critical for Regenerative Medicine and Immunotherapy?

Cell expansion is indispensable for the advancement of regenerative medicine and immunotherapy, two of the most promising fields in modern healthcare. Regenerative medicine relies heavily on stem cells, which have the ability to differentiate into various cell types and repair damaged tissues. To create effective treatments for conditions such as spinal cord injuries, heart disease, or diabetes, researchers must expand stem cells in large quantities. The challenge lies in maintaining the pluripotency of these cells during the expansion process, ensuring that they retain their capacity to transform into the needed cell types. Immunotherapy, on the other hand, depends on the expansion of immune cells like T cells, which are modified and multiplied to fight diseases such as cancer. The success of CAR-T cell therapy, for instance, hinges on the ability to expand these engineered T cells to sufficient numbers to achieve therapeutic efficacy. The growing adoption of these therapies has increased the need for robust cell expansion systems that can support large-scale production without compromising the safety and potency of the cells. As the demand for cell-based therapies continues to rise, cell expansion technologies are becoming more sophisticated to meet the challenges of scalability and regulatory compliance in clinical applications.

How Are Technological Advancements Revolutionizing Cell Expansion?

Technological advancements are revolutionizing the process of cell expansion, making it more efficient, scalable, and adaptable to the needs of modern science. One of the most significant innovations is the development of bioreactors, which provide controlled environments for cell growth, enabling the expansion of cells on a large scale while maintaining optimal conditions for viability and function. These bioreactors are equipped with automated systems that monitor and adjust critical parameters such as temperature, oxygen, and nutrient levels, ensuring consistent and reproducible results. Additionally, innovations in culture media have made it possible to optimize the nutritional needs of specific cell types, further improving the quality and yield of expanded cells. Microcarriers, which offer a surface for cells to grow in suspension, have expanded the capacity of bioreactors, making them more efficient in producing high cell densities. Advances in automation and artificial intelligence (AI) are also playing a crucial role, enabling real-time monitoring and decision-making in cell culture environments. These technologies help researchers and clinicians streamline the cell expansion process, reducing the time and cost associated with producing therapeutic cells while increasing scalability for clinical and industrial use.

What Factors Are Driving Growth in the Cell Expansion Market?

The growth in the cell expansion market is driven by several factors, including the increasing demand for cell-based therapies, advancements in bioprocessing technologies, and the growing prevalence of chronic diseases. As more cell-based therapies, such as CAR-T cell treatments and stem cell therapies, enter clinical practice, the need for reliable and scalable cell expansion methods is rising rapidly. Technological innovations, particularly in bioreactors and automation, have made it easier to produce large quantities of cells while maintaining their quality and therapeutic potential. The expanding use of cell expansion in regenerative medicine, where stem cells are employed to repair or replace damaged tissues, is another significant driver, as it requires efficient and scalable systems to produce the high volumes of cells necessary for these treatments. Moreover, the growing incidence of cancer, diabetes, and cardiovascular diseases is fueling research into new therapies that depend on expanded cells, such as immunotherapies and regenerative treatments. Additionally, regulatory advancements in the approval of cell-based therapies are encouraging investments in bioprocessing infrastructure, further propelling market growth. As consumer awareness of personalized medicine increases, the demand for customized cell therapies is expected to accelerate, creating new opportunities for the development of innovative cell expansion technologies. These factors are collectively driving the rapid expansion of the cell expansion market, positioning it as a key area of growth in biotechnology and healthcare.

Select Competitors (Total 12 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â